Patent details

EP4056590 Title: BIOPHARMACEUTICAL COMPOSITIONS

Basic Information

Publication number:
EP4056590
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP221526288
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BIOPHARMACEUTICAL COMPOSITIONS
French Title of Invention:
COMPOSITIONS BIOPHARMACEUTIQUES
German Title of Invention:
BIOPHARMAZEUTISCHE ZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
22/08/2016
Grant date:
15/10/2025
EP Publication Date:
14/09/2022
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/10/2025
EP B1 Publication Date:
15/10/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
22/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/10/2025
 
 

Name:
GlaxoSmithKline Intellectual Property (No.2) Limited
Address:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom (GB)

Inventor

1

Name:
DALLY, Jennifer
Address:
United States (US)

2

Name:
SPATARA, Michelle
Address:
United States (US)

3

Name:
MONCK, Myrna, A
Address:
United States (US)

4

Name:
BAM, Narendra, B
Address:
United States (US)

Priority

1

Priority Number:
201562209000 P
Priority Date:
24/08/2015
Priority Country:
United States (US)

2

Priority Number:
201562240131 P
Priority Date:
12/10/2015
Priority Country:
United States (US)

3

Priority Number:
201562247906 P
Priority Date:
29/10/2015
Priority Country:
United States (US)

4

Priority Number:
201562249497 P
Priority Date:
02/11/2015
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/24; C07K 1/16; A61P 9/00; A61P 1/04; A61P 37/08; A61P 17/02; A61P 11/06; A61P 11/02;

Publication

European Patent Bulletin

Issue number:
202542
Publication date:
15/10/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages